PATTIES FOODS (PH4) - Total Assets

Latest as of December 2025: €1.36 Billion EUR ≈ $1.59 Billion USD

Based on the latest financial reports, PATTIES FOODS (PH4) holds total assets worth €1.36 Billion EUR (≈ $1.59 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See PH4 book value for net asset value and shareholders' equity analysis.

PATTIES FOODS - Total Assets Trend (2020–2025)

This chart illustrates how PATTIES FOODS's total assets have evolved over time, based on quarterly financial data.

PATTIES FOODS - Asset Composition Analysis

Current Asset Composition (December 2025)

PATTIES FOODS's total assets of €1.36 Billion consist of 82.0% current assets and 18.1% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 55.5%
Accounts Receivable €33.81 Million 2.5%
Inventory €116.89 Million 8.6%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €149.69 Million 11.0%
Goodwill €0.00 0.0%

Asset Composition Trend (2020–2025)

This chart illustrates how PATTIES FOODS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PATTIES FOODS market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: PATTIES FOODS's current assets represent 82.0% of total assets in 2025, a decrease from 94.9% in 2020.
  • Cash Position: Cash and equivalents constituted 55.5% of total assets in 2025, down from 80.4% in 2020.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2020.
  • Asset Diversification: The largest asset category is intangible assets at 11.0% of total assets.

PATTIES FOODS Competitors by Total Assets

Key competitors of PATTIES FOODS based on total assets are shown below.

Company Country Total Assets
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT
USA $107.75 Million
Halozyme Therapeutics Inc
NASDAQ:HALO
USA $2.22 Billion
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
China CN¥16.55 Billion
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
USA $1.53 Billion
Inner Mongolia Furui Med Sci
SHE:300049
China CN¥3.42 Billion
Bio-Thera Solutions Ltd
SHG:688177
China CN¥2.39 Billion
Wuhan Keqian Biology Co Ltd
SHG:688526
China CN¥4.75 Billion
Gubra A/S
CO:GUBRA
Denmark Dkr1.32 Billion

PATTIES FOODS - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.18 1.60 1.56
Quick Ratio 1.95 1.18 1.44
Cash Ratio 0.00 0.00 0.00
Working Capital €602.97 Million €407.90 Million €479.45 Million

PATTIES FOODS - Advanced Valuation Insights

This section examines the relationship between PATTIES FOODS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 18.61
Latest Market Cap to Assets Ratio 1.06
Asset Growth Rate (YoY) -2.5%
Total Assets €1.36 Billion
Market Capitalization $1.44 Billion USD

Valuation Analysis

Above Book Valuation: The market values PATTIES FOODS's assets above their book value (1.06x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: PATTIES FOODS's assets decreased by 2.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for PATTIES FOODS (2020–2025)

The table below shows the annual total assets of PATTIES FOODS from 2020 to 2025.

Year Total Assets Change
2025-12-31 €1.36 Billion
≈ $1.59 Billion
-2.52%
2024-12-31 €1.39 Billion
≈ $1.63 Billion
-16.16%
2023-12-31 €1.66 Billion
≈ $1.94 Billion
+1.44%
2022-12-31 €1.64 Billion
≈ $1.92 Billion
-27.87%
2021-12-31 €2.27 Billion
≈ $2.66 Billion
-39.63%
2020-12-31 €3.76 Billion
≈ $4.40 Billion
--

About PATTIES FOODS

F:PH4 Germany Biotechnology
Market Cap
$1.58 Billion
€1.35 Billion EUR
Market Cap Rank
#7585 Global
#1036 in Germany
Share Price
€0.84
Change (1 day)
+1.35%
52-Week Range
€0.39 - €1.35
All Time High
€1.35
About

CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more